Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
3983.HK Stock Summary
Top 10 Correlated ETFs
3983.HK
In the News
3983.HK Financial details
Company Rating
Strong Buy
Market Cap
11.12B
Income
3.61B
Revenue
27.74B
Book val./share
3.83
Cash/share
2.51
Dividend
0.2
Dividend %
9.79%
Employees
4.07K
Optionable
No
Shortable
Yes
Earnings
23 Mar 2024
P/E
5.22
Forward P/E
6.65
PEG
0.37
P/S
0.6
P/B
0.51
P/C
0.9
P/FCF
10.67
Quick Ratio
3.06
Current Ratio
3.77
Debt / Equity
0.11
LT Debt / Equity
0.08
-
-
EPS (TTM)
0.77
EPS next Y
0.34
EPS next Q
-
EPS this Y
12.5%
EPS next Y
-55.78%
EPS next 5Y
-55.78%
EPS last 5Y
3.71%
Revenue last 5Y
4.87%
Revenue Q/Q
-10.6%
EPS Q/Q
146.67%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
0.01%
Inst Trans
0.4%
ROA
7%
ROE
10%
ROC
0.11%
Gross Margin
18%
Oper. Margin
16%
Profit Margin
12%
Payout
44%
Shs Outstand
4.59B
Shs Float
3.88B
-
-
-
-
Target Price
-
52W Range
1.69-2.48
52W High
+13%
52W Low
+126%
RSI
48
Rel Volume
1.41
Avg Volume
3.64M
Volume
5.11M
Perf Week
-3.42%
Perf Month
4.63%
Perf Quarter
20.21%
Perf Half Y
18.95%
-
-
-
-
Beta
0.943
-
-
Volatility
0.04%, 0.06%
Prev Close
-1.74%
Price
2.26
Change
-0.88%
3983.HK Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 2.44 | 2.36 | 2.26 | 2.91 | 3.1 | |
Net income per share | 0.3 | 0.15 | 0.16 | 0.32 | 0.36 | |
Operating cash flow per share | 0.43 | 0.25 | 0.27 | 0.64 | 0.46 | |
Free cash flow per share | 0.4 | 0.17 | 0.19 | 0.41 | 0.17 | |
Cash per share | 1.91 | 1.3 | 2.21 | 1.89 | 2.04 | |
Book value per share | 3.08 | 3.1 | 3.19 | 3.43 | 3.63 | |
Tangible book value per share | 3.27 | 3.27 | 3.38 | 3.66 | 3.85 | |
Share holders equity per share | 3.08 | 3.1 | 3.19 | 3.43 | 3.63 | |
Interest debt per share | 0.47 | 0.46 | 0.44 | 0.23 | 0.46 | |
Market cap | 9.95B | 7.9B | 4.81B | 8.16B | 7.53B | |
Enterprise value | 8.67B | 9.11B | 4.02B | 8.54B | 9.08B | |
P/E ratio | 7.22 | 11.24 | 6.45 | 5.45 | 4.59 | |
Price to sales ratio | 0.88 | 0.73 | 0.46 | 0.61 | 0.53 | |
POCF ratio | 4.96 | 6.92 | 3.81 | 2.78 | 3.52 | |
PFCF ratio | 5.4 | 10.09 | 5.4 | 4.34 | 9.34 | |
P/B Ratio | 0.7 | 0.55 | 0.33 | 0.52 | 0.45 | |
PTB ratio | 0.7 | 0.55 | 0.33 | 0.52 | 0.45 | |
EV to sales | 0.77 | 0.84 | 0.39 | 0.64 | 0.64 | |
Enterprise value over EBITDA | 3.54 | 5.74 | 3.05 | 3.1 | 3.86 | |
EV to operating cash flow | 4.33 | 7.98 | 3.18 | 2.9 | 4.24 | |
EV to free cash flow | 4.71 | 11.64 | 4.52 | 4.54 | 11.26 | |
Earnings yield | 0.14 | 0.09 | 0.15 | 0.18 | 0.22 | |
Free cash flow yield | 0.19 | 0.1 | 0.19 | 0.23 | 0.11 | |
Debt to equity | 0.15 | 0.14 | 0.13 | 0.06 | 0.12 | |
Debt to assets | 0.11 | 0.1 | 0.09 | 0.05 | 0.09 | |
Net debt to EBITDA | -0.52 | 0.76 | -0.6 | 0.13 | 0.66 | |
Current ratio | 2.88 | 2.99 | 2.59 | 3.91 | 3.77 | |
Interest coverage | 35.56 | 9.32 | 9.08 | 44.01 | 62.05 | |
Income quality | 1.45 | 1.62 | 1.69 | 1.96 | 1.3 | |
Dividend Yield | 0 | 0.09 | 0.07 | 0.05 | 0.09 | |
Payout ratio | 0.02 | 0.98 | 0.47 | 0.25 | 0.44 | |
Sales general and administrative to revenue | 0.04 | 0.05 | 0.04 | 0.04 | 0.04 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | -0.08 | -0.31 | -0.3 | -0.36 | -0.62 | |
Capex to revenue | -0.01 | -0.03 | -0.04 | -0.08 | -0.09 | |
Capex to depreciation | -0.23 | -0.51 | -0.58 | -1.92 | -2.38 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 4.55 | 3.26 | 3.41 | 5.01 | 5.4 | |
ROIC | 0.07 | 0.03 | 0.03 | 0.08 | 0.08 | |
Return on tangible assets | 0.07 | 0.04 | 0.04 | 0.07 | 0.07 | |
Graham Net | 1.03 | 0.56 | 1.31 | 1.08 | 1 | |
Working capital | 7.01B | 7.25B | 7.78B | 10.02B | 11.38B | |
Tangible asset value | 15.09B | 15.09B | 15.6B | 16.87B | 17.74B | |
Net current asset value | 5.92B | 6.58B | 7.57B | 8.94B | 9.76B | |
Invested capital | 0.15 | 0.14 | 0.13 | 0.06 | 0.12 | |
Average receivables | 234.99M | 297.81M | 536.61M | 434.28M | 326.27M | |
Average payables | 798.96M | 698.43M | 714.44M | 1.04B | 1.34B | |
Average inventory | 1.25B | 1.2B | 1.06B | 1.12B | 1.21B | |
Days sales outstanding | 5.56 | 14.26 | 22.74 | 5.98 | 11.07 | |
Days payables outstanding | 30.41 | 28.12 | 29.75 | 46.59 | 41.85 | |
Days of inventory on hand | 55.23 | 45.36 | 40.24 | 42.97 | 36.99 | |
Receivables turnover | 65.68 | 25.6 | 16.05 | 61.03 | 32.98 | |
Payables turnover | 12 | 12.98 | 12.27 | 7.83 | 8.72 | |
Inventory turnover | 6.61 | 8.05 | 9.07 | 8.49 | 9.87 | |
ROE | 0.1 | 0.05 | 0.05 | 0.09 | 0.1 | |
Capex per share | -0.04 | -0.08 | -0.08 | -0.23 | -0.29 |
Quarterly Fundamentals Overview
Last date of statement is 2023-06-30 for Q2
Metric | History | 2021-06-30 | 2021-12-31 | 2022-06-30 | 2022-12-31 | 2023-06-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 1.33 | 1.58 | 1.6 | 1.5 | 1.34 | |
Net income per share | 0.27 | 0.05 | 0.2 | 0.15 | 0.37 | |
Operating cash flow per share | 0.24 | 0.4 | 0.16 | 0.3 | 0.08 | |
Free cash flow per share | 0.17 | 0.24 | 0.05 | 0.13 | 0.02 | |
Cash per share | 2.03 | 1.89 | 1.97 | 2.04 | 2.51 | |
Book value per share | 3.38 | 3.43 | 3.48 | 3.63 | 3.83 | |
Tangible book value per share | 3.59 | 3.66 | 3.7 | 3.85 | 4.06 | |
Share holders equity per share | 3.38 | 3.43 | 3.48 | 3.63 | 3.83 | |
Interest debt per share | 0.21 | 0.22 | 0.35 | 0.45 | 0.44 | |
Market cap | 8.71B | 8.16B | 8.89B | 7.53B | 7.5B | |
Enterprise value | 8.89B | 8.54B | 9.67B | 9.08B | 8.45B | |
P/E ratio | 1.75 | 8.11 | 2.37 | 2.67 | 1.09 | |
Price to sales ratio | 1.43 | 1.12 | 1.21 | 1.09 | 1.21 | |
POCF ratio | 7.82 | 4.48 | 11.94 | 5.39 | 19.81 | |
PFCF ratio | 11.23 | 7.4 | 38.63 | 13.06 | 102.22 | |
P/B Ratio | 0.56 | 0.52 | 0.55 | 0.45 | 0.43 | |
PTB ratio | 0.56 | 0.52 | 0.55 | 0.45 | 0.43 | |
EV to sales | 1.46 | 1.17 | 1.31 | 1.31 | 1.37 | |
Enterprise value over EBITDA | 7.11 | 5.66 | 7.23 | 8.97 | 8.49 | |
EV to operating cash flow | 7.98 | 4.68 | 12.98 | 6.5 | 22.32 | |
EV to free cash flow | 11.47 | 7.73 | 41.99 | 15.75 | 115.18 | |
Earnings yield | 0.14 | 0.03 | 0.11 | 0.09 | 0.23 | |
Free cash flow yield | 0.09 | 0.14 | 0.03 | 0.08 | 0.01 | |
Debt to equity | 0.06 | 0.06 | 0.1 | 0.12 | 0.11 | |
Debt to assets | 0.05 | 0.05 | 0.07 | 0.09 | 0.08 | |
Net debt to EBITDA | 0.14 | 0.25 | 0.58 | 1.53 | 0.96 | |
Current ratio | 3.36 | 3.91 | 3.98 | 3.77 | 4.73 | |
Interest coverage | 0 | 0 | 0 | 0 | 0 | |
Income quality | 0.89 | 7.24 | 0.79 | 1.98 | 0.22 | |
Dividend Yield | 0.04 | 0 | 0.08 | 0 | 0.11 | |
Payout ratio | 0.3 | 0 | 0.76 | 0 | 0.48 | |
Sales general and administrative to revenue | 0.04 | 0.04 | 0.03 | 0.04 | 0.04 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | -0.3 | -0.4 | -0.69 | -0.59 | -0.81 | |
Capex to revenue | -0.06 | -0.1 | -0.07 | -0.12 | -0.05 | |
Capex to depreciation | -1.24 | -2.59 | -1.95 | -2.77 | -1.16 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 4.53 | 2.05 | 3.99 | 3.54 | 5.66 | |
ROIC | 0.05 | 0.03 | 0.05 | 0.03 | 0.04 | |
Return on tangible assets | 0.06 | 0.01 | 0.04 | 0.03 | 0.07 | |
Graham Net | 1.38 | 1.08 | 1.11 | 1 | 1.62 | |
Working capital | 9.13B | 10.02B | 10.44B | 11.38B | 11.51B | |
Tangible asset value | 16.57B | 16.87B | 17.05B | 17.74B | 18.7B | |
Net current asset value | 8.93B | 8.94B | 9B | 9.76B | 9.67B | |
Invested capital | 0.06 | 0.06 | 0.1 | 0.12 | 0.11 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 0 | 0 | 0 | 0 | 0 | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 9.27 | 2.71 | 3.74 | 5.64 | 2.86 | |
Days payables outstanding | 19.01 | 21.32 | 21.06 | 20.97 | 20.76 | |
Days of inventory on hand | 21.83 | 19.66 | 22.75 | 18.53 | 23.73 | |
Receivables turnover | 9.71 | 33.2 | 24.08 | 15.95 | 31.43 | |
Payables turnover | 4.73 | 4.22 | 4.27 | 4.29 | 4.34 | |
Inventory turnover | 4.12 | 4.58 | 3.96 | 4.86 | 3.79 | |
ROE | 0.08 | 0.02 | 0.06 | 0.04 | 0.1 | |
Capex per share | -0.07 | -0.16 | -0.11 | -0.18 | -0.07 |
3983.HK Frequently Asked Questions
What is China BlueChemical Ltd. stock symbol ?
China BlueChemical Ltd. is a CN stock and trading under the symbol 3983.HK
What is China BlueChemical Ltd. stock quote today ?
China BlueChemical Ltd. stock price is $2.26 today.
Is China BlueChemical Ltd. stock public?
Yes, China BlueChemical Ltd. is a publicly traded company.